Our annual trend report for the Swiss life sciences market proves that Switzerland remains one of the most important locations in the life science industry. In 2016, Swiss biotechnology companies attracted funding worth nearly 400 million USD in total.
Switzerland LS Trend Analysis 2017
Looking for your next Biotech or Medtech partner?
Use Biotechgate to identify new leads, licensing opportunities and management details.